Evolution and Current Circumstances of Heart Transplants: Global and Mexican Perspective

被引:7
作者
Rangel-Ugarte, Paula-Mariana [1 ]
Ramirez-Castaneda, Serafin [2 ]
Mendoza-Lopez, Abril-Carolina [3 ,4 ]
Gonzalez-Hermosillo, Leslie-Marisol [3 ]
Flores-Calderon, Octavio [2 ]
Salazar-Hernandez, Ignacio [2 ]
Ramirez-Castaneda, Alberto [2 ]
Roldan-Valadez, Ernesto [3 ,5 ]
机构
[1] Natl Polytech Inst, Super Sch Med, Mexico City, DF, Mexico
[2] Hosp Gen Mexico Dr Eduardo Liceaga, Cardiothorac Surg Dept, Mexico City, DF, Mexico
[3] Hosp Gen Mexico Dr Eduardo Liceaga, Directorate Res, Mexico City, DF, Mexico
[4] Benemerita Univ Autonoma Puebla, Fac Med, Puebla, Mexico
[5] IM Sechenov First Moscow State Med Univ, Dept Radiol, Sechenov Univ, Moscow, Russia
关键词
ORTHOTOPIC CARDIAC TRANSPLANTATION; ORGAN DONATION; DRUG-THERAPY; BRAIN-DEATH; RECIPIENT; BICAVAL;
D O I
10.1016/j.cpcardiol.2022.101316
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A cardiac transplant is an irreplaceable alternative for patients with terminal chronic heart failure refractive to treatment. Heart failure results from an imbalance between cardiac output and organic demand, the prominent etiology is ischemic heart disease and arterial hypertension. In developed countries, it has a prevalence of 4.2%, reaching over 11.8% in adults over 65. It affects around 64.3 million people worldwide, with 9 cases for every 1000 people. This syndrome has a death rate of 56% in 5 years, making heart transplants relevant. The procedure has dramatically evolved from the beginning of animal experimentation in the early 20th century to now, where significant advances are still being made. The purpose of this review is to compile the central aspects of international and Mexico's local heart transplant history and current status, as well as a general view of what this procedure entails and possible prospective outcomes for this practice.
引用
收藏
页数:20
相关论文
共 43 条
[21]   Drug therapy in the heart transplant recipient - Part II: Immunosuppressive drugs [J].
Lindenfeld, J ;
Miller, GG ;
Shakar, SF ;
Zolty, R ;
Lowes, BD ;
Wolfel, EE ;
Mestroni, L ;
Page, RL ;
Kobashigawa, J .
CIRCULATION, 2004, 110 (25) :3858-3865
[22]   Drug therapy in the heart transplant recipient - Part I: Cardiac rejection and immunosuppressive drugs [J].
Lindenfeld, JA ;
Miller, GG ;
Shakar, SF ;
Zolty, R ;
Lowes, BD ;
Wolfel, EE ;
Mestroni, L ;
Page, RL ;
Kobashigawa, J .
CIRCULATION, 2004, 110 (24) :3734-3740
[23]   Immunosuppression and infection in transplant recipients [J].
Martin-Davila, Pilar ;
Blanes, Marino ;
Fortun, Jesus .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2007, 25 (02) :143-154
[24]   FIVE THINGS TO KNOW ABOUT ... Chronic heart failure with reduced ejection fraction [J].
Moayedi, Yasbanoo ;
Kobulnik, Jeremy .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2015, 187 (07) :518-518
[25]   Orthotopic cardiac transplantation: Comparison of outcome using biatrial, bicaval, and total techniques [J].
Morgan, JA ;
Edwards, NM .
JOURNAL OF CARDIAC SURGERY, 2005, 20 (01) :102-106
[26]  
Olivares-Dur R, 2022, NEW ENGL J MED, V158, P93
[27]   Experience with transplant coordination in northern Mexico following the Spanish model [J].
Osio, I ;
Escobedo, M ;
Chavarria, U ;
Pérez, E ;
Martinez, A ;
Rodriguez, A ;
Guedea, M ;
Maldonado, JP ;
Rodriguez-Montalvo, C .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) :19-19
[28]   Impact of Religion on Opinions About Organ Donation and Transplantation in University Students From a Single University in Turkey [J].
Ozsoy, Balin ;
Herrera-Gayol, Andrea ;
Unal, Yasemin ;
Askar, Medhat ;
Haberal, Mehmet ;
Cantarovich, Marcelo .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2021, 19 (07) :645-650
[29]  
Parra BA, 2014, J HIGH ENERGY PHYS, V22, P106
[30]  
Rayner M, 2019, YALE J BIOL MED, V92, P751